THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The existing scenario has uncovered some structural weaknesses inside the EU’s medicines provide chain and a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain problems be resolved within an EU pharmaceutical strategy envisioned to generally be launched by